Arbutus Biopharma Corp. (ABUS) stock surged during pre-market trading. Why is it so?
Arbutus Biopharma Corp. (NASDAQ: ABUS) stock gained by 2.43% at last close whereas the ABUS stock price surges by 14.54% in the pre-market trading.Arbutus Biopharma Corporation is a publicly listed pharmaceutical firm whose primary goal is to find, develop, and commercialize a treatment for chronic hepatitis B virus (HBV) infection. >> 7 Top Picks for […]